STAT+: Insilico inks cancer drug deal with Servier after IPO

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Welcome back and happy new year!

We have plenty of fresh coverage to start the week. We can also report that our upcoming STAT@JPM event — featuring Richard Pazdur and Yvonne Greenstreet, among others — is sold out. There’s a waitlist if you’d like to sign up.